K Maddocks-Christianson, SL Slager, CS Zent … - British journal of haematology, 2007 - interscience.wiley.com Previous studies suggested that patients with chronic lymphocytic leukaemia
(CLL) are at a three- to fivefold increased risk of developing a second
lymphoproliferative disorder (LPD). This observational cohort study used ... Cited by 16 - Related articles - BL Direct - All 4 versions
JB Weinberg, AD Volkheimer, Y Chen, BE … - American Journal of Hematology, 2007 - interscience.wiley.com Several parameters may predict disease severity and overall survival in chronic
lymphocytic leukemia (CLL). The purpose of our study of 190 CLL patients was to
compare immunoglobulin heavy chain variable region (IgV H ) mutation ... Cited by 8 - Related articles - BL Direct - All 2 versions
- ►nih.gov RC Tschumper, SM Geyer, ME Campbell, NE … - Journal of Clinical Investigation, 2007 - Am Soc Clin Investig Survival of patients with B cell chronic lymphocytic leukemia (B-CLL) can be
predicted by analysis of mutations in the immunoglobulin heavy chain variable
gene (IGHV). Patients without mutations (unmutated [UM]) are at greater ... Cited by 4 - Related articles - BL Direct - All 7 versions
C Nabhan, TD Shanafelt, NE Kay - Leukemia Research, 2008 - Elsevier Once considered a simple homogeneous disease, chronic lymphocytic leukemia (CLL)
is now recognized to be a heterogeneous lymphoid malignancy with patients
classified into low, intermediate, and high-risk categories based on ... Cited by 4 - Related articles - All 5 versions
M Kalaycio - Clinical Leukemia, 2008 - CIG Media Group Introduction Chronic lymphocytic leukemia (CLL) is the most common form of adult
leukemia, estimated to comprise over one third of all new leukemia cases.1 The
American Cancer Society estimates that in 2008, 15,110 new cases of CLL ... Related articles - All 8 versions
- ►hematologylibrary.org J Delgado, DW Milligan, P Dreger - Blood, 2009 - bloodjournal.hematologylibrary.org The development of reduced intensity conditioning regimens has increased the
number of patients diagnosed with chronic lymphocytic leukemia that are referred
for allogeneic hematopoietic cell transplantation (allo-HCT). However, ... Related articles - All 2 versions
MS Czuczman - millennium-cme.com Release Date: January 2008 Expiration Date: January 31, 2009 ... Millennium CME
Institute, Inc. is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians. Related articles - View as HTML
KC Keen, 2009 - etd.ohiolink.edu Page 1. USE OF CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH CONSORTIUM DATA
REPOSITORY AND GENE EXPRESSION OMNIBUS TO GENERATE AND TEST ... Related articles - View as HTML - All 6 versions
L Boissel, M Betancur, WS Wels, H Tuncer, H … - Leukemia Research, 2009 - Elsevier An emerging treatment option for chronic lymphocytic leukemia (CLL) is to make
cytotoxic immune cells express a chimeric antigen receptor (CAR) that recognizes
specific surface molecules on CLL cells. Here an mRNA coding for an ... Related articles - All 9 versions
S Serefhanoglu, Y Buyukasik, H Goker, SC … - Medical Oncology - Springer Abstract Appearance of non-Hodgkin's lymphomas (NHL) and renal cell carcinoma
(RCC) in same person has been reported in the literature. There is a
higher-than- expected incidence of co-occurrence of these neoplastic ... Related articles - All 2 versions
